[3P-515] Treatment of lipolysis-stimulated lipoprotein receptor (LSR) antibody with HDAC inhibitors promotes apoptosis in human salivary duct adenocarcinoma

^○soshi Nishida^1,2, Masaya Nakano², Kizuku Owada², Takumi Konno¹, Takayuki Kohno¹, Akito Kakiuchi², Kazufumi Obata², Makoto Kurose², Kenichi Takano², Takashi Kojima¹ (1.Dept. of Cell. Sci., Res. Ins. for Frontier Med., Sapporo Med. Univ. Sch. of Med, 2.Dept.of Otolaryngology., Sapporo Med. Univ.Med. Sch.)